Iberia Capital Upgrades Core Laboratories (CLB) to Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- US futures fall on tech selloff as concerns about hawkish Fed, AI spending mount
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Core Lab Reports Q1 2015 EPS Of $0.86, Ex-Items; Record Q1 FCF Tops $72 Million; Share Count Falls Below 44 Million, A New 17-Year Low
April 22, 2015 4:29 PM EDTAMSTERDAM, April 22, 2015 /PRNewswire/ -- Core Laboratories N.V. (NYSE: "CLB US")(Euronext Amsterdam: "CLB NA") reported first quarter 2015 earnings per diluted share ("EPS") of $0.86, excluding items ("ex-items") which are primarily employee severance costs and are referenced in the non-GAAP reconciliation included in this release. First quarter 2015 net income, ex-items, totaled $37,500,000, while revenue was $213,600,000, down 19% from first quarter 2014 levels. Year-over-year first quarter revenue was negatively affected by approximately $8,500,000, or 4%, in foreign currency exchange rate changes versus the U.S. dollar. Operating income, ex-items, was $50,700,000, yielding operating margins of 24%.
Free cash flow ("FCF"), defined as cash from operations... More
